Study periods
This system update allows even more studies to be built in Oracle Clinical One Platform, including:
- Open-label studies
- Studies with both blinded and open-label periods
- Studies with re-randomizations
Now in an open-label period or study, unblinded information can be made visible to blinded users.
Not planning to use these features?
You'll still see some changes to the interface, including some improvements that will help you even if you're not doing an open-label study or a second randomization. Keep reading for details.
Read more about how this change affects...